BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35333324)

  • 21. A novel CSF1R variant in a South Dakota family with CSF1R-related leukoencephalopathy.
    Ali S; Tipton PW; Koga S; Middlebrooks EH; Josephs KA; Strongosky A; Dickson DW; Wszolek ZK
    Parkinsonism Relat Disord; 2022 Sep; 102():51-53. PubMed ID: 35940158
    [No Abstract]   [Full Text] [Related]  

  • 22. Proteolytic Shedding of Human Colony-Stimulating Factor 1 Receptor and its implication.
    Wei Y; Ma M; Lin S; Li X; Shu Y; Wang Z; Zhou Y; Hu B; Cheng B; Duan S; Huang X; Xu H; Zhang YW; Zheng H
    J Cell Mol Med; 2021 May; 25(9):4516-4521. PubMed ID: 33783963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia Caused by a Novel R782G Mutation in CSF1R.
    Foulds N; Pengelly RJ; Hammans SR; Nicoll JA; Ellison DW; Ditchfield A; Beck S; Ennis S
    Sci Rep; 2015 May; 5():10042. PubMed ID: 25975230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AARS2 Compound Heterozygous Variants in a Case of Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.
    Wang D; Yu M; Zhang W; Wang Z; Yuan Y
    J Neuropathol Exp Neurol; 2018 Nov; 77(11):997-1000. PubMed ID: 30272204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of a novel CSF1R mutation causing hereditary diffuse leukoencephalopathy with spheroids.
    Kraya T; Quandt D; Pfirrmann T; Kindermann A; Lampe L; Schroeter ML; Kohlhase J; Stoevesandt D; Hoffmann K; Villavicencio-Lorini P
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00595. PubMed ID: 30729751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.
    Guo L; Bertola DR; Takanohashi A; Saito A; Segawa Y; Yokota T; Ishibashi S; Nishida Y; Yamamoto GL; Franco JFDS; Honjo RS; Kim CA; Musso CM; Timmons M; Pizzino A; Taft RJ; Lajoie B; Knight MA; Fischbeck KH; Singleton AB; Ferreira CR; Wang Z; Yan L; Garbern JY; Simsek-Kiper PO; Ohashi H; Robey PG; Boyde A; Matsumoto N; Miyake N; Spranger J; Schiffmann R; Vanderver A; Nishimura G; Passos-Bueno MRDS; Simons C; Ishikawa K; Ikegawa S
    Am J Hum Genet; 2019 May; 104(5):925-935. PubMed ID: 30982609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predictive of the presence of a CSF1R mutation in patients with leukoencephalopathy.
    Kondo Y; Matsushima A; Nagasaki S; Nakamura K; Sekijima Y; Yoshida K
    Eur J Neurol; 2020 Feb; 27(2):369-375. PubMed ID: 31520500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS): new cases, systematic literature review, and associations with CSF1R-ALSP.
    Dulski J; Souza J; Santos ML; Wszolek ZK
    Orphanet J Rare Dis; 2023 Jun; 18(1):160. PubMed ID: 37349768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A young-onset frontal dementia with dramatic calcifications due to a novel CSF1R mutation.
    Gore E; Manley A; Dees D; Appleby BS; Lerner AJ
    Neurocase; 2016 Jun; 22(3):257-62. PubMed ID: 27092868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia.
    Gelfand JM; Greenfield AL; Barkovich M; Mendelsohn BA; Van Haren K; Hess CP; Mannis GN
    Brain; 2020 Feb; 143(2):503-511. PubMed ID: 31840744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial loss of function of colony-stimulating factor 1 receptor in a patient with white matter abnormalities.
    Konno T; Miura T; Harriott AM; Mezaki N; Edwards ES; Rademakers R; Ross OA; Meschia JF; Ikeuchi T; Wszolek ZK
    Eur J Neurol; 2018 Jun; 25(6):875-881. PubMed ID: 29509319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel dominant-negative mutation of the CSF1R gene causes adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
    Leng C; Lu L; Wang G; Zhang Y; Xu Y; Lin X; Shen N; Xu X; Qun S; Sun M; Ge W
    Am J Transl Res; 2019; 11(9):6093-6101. PubMed ID: 31632577
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Konno T; Kasanuki K; Ikeuchi T; Dickson DW; Wszolek ZK
    Neurology; 2018 Dec; 91(24):1092-1104. PubMed ID: 30429277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Loss of homeostatic microglia in rare neurological disorders: implications for cell transplantation].
    Ikeuchi T; Fitrah YA; Shu B
    Nihon Yakurigaku Zasshi; 2021; 156(4):225-229. PubMed ID: 34193701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mutation in CSF1R associated with hereditary diffuse leukoencephalopathy with spheroids.
    Du Q; Wang M; Zhou H
    Neurol Sci; 2022 Jan; 43(1):411-417. PubMed ID: 33948764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD).
    Adams SJ; Kirk A; Auer RN
    J Clin Neurosci; 2018 Feb; 48():42-49. PubMed ID: 29122458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of an induced pluripotent stem cell line from a patient with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): HIHCNi003-A.
    Hayer SN; Schelling Y; Hoeflinger P; Hauser S; Schöls L
    Stem Cell Res; 2018 Jul; 30():206-209. PubMed ID: 29980109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From HDLS to BANDDOS: fast-expanding phenotypic spectrum of disorders caused by mutations in CSF1R.
    Guo L; Ikegawa S
    J Hum Genet; 2021 Dec; 66(12):1139-1144. PubMed ID: 34135456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of homozygous and heterozygous Csf1r knockout in the rat as a model for understanding microglial function in brain development and the impacts of human CSF1R mutations.
    Patkar OL; Caruso M; Teakle N; Keshvari S; Bush SJ; Pridans C; Belmer A; Summers KM; Irvine KM; Hume DA
    Neurobiol Dis; 2021 Apr; 151():105268. PubMed ID: 33450391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further expanding the mutational spectrum of brain abnormalities, neurodegeneration, and dysosteosclerosis: A rare disorder with neurologic regression and skeletal features.
    Kındış E; Simsek-Kiper PÖ; Koşukcu C; Taşkıran EZ; Göçmen R; Utine E; Haliloğlu G; Boduroğlu K; Alikaşifoğlu M
    Am J Med Genet A; 2021 Jun; 185(6):1888-1896. PubMed ID: 33749994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.